Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cavo

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Expert Review of Hematology|December 5, 2015
Current and emerging triplet combination therapies for relapsed and refractory multiple myelomaL Pantani, A Brioli, P Tacchetti, et al.
Journal of Experimental Pathology|January 1, 1987
Production and characterization of monoclonal antibodies (MoAbs) for the ex vivo purging of the bone marrow in patients with multiple myelomaA Dinota, P L Tazzari, A Bontadini, et al.
Pathologie-Biologie|October 1, 1990
Therapy of multiple myeloma. Italian Multiple Myeloma Study GroupM Boccadoro, G Avvisati, M Cantonetti, et al.
Cancer|February 15, 1982
Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemiaP Nanni, G Nicoletti, G Prodi, et al.
Transplantation|February 1, 1989
Bone marrow purging for multiple myeloma by avidin-biotin immunoadsorptionR M Lemoli, M Gobbi, P L Tazzari, et al.
Neurology|August 8, 2007
Neuropathy in multiple myeloma treated with thalidomide: a prospective studyR Plasmati, F Pastorelli, M Cavo, et al.
Haematologica|May 18, 1999
Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cellsG Martinelli, C Terragna, R M Lemoli, et al.
Blood|March 25, 2000
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapyR M Lemoli, G Martinelli, E Zamagni, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 25, 2019
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitorsM Mancini, S De Santis, C Monaldi, et al.
Leukemia|April 17, 2009
Ascorbic acid inhibits antitumor activity of bortezomib in vivoG Perrone, T Hideshima, H Ikeda, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Expert Review of Hematology|December 5, 2015
Current and emerging triplet combination therapies for relapsed and refractory multiple myelomaL Pantani, A Brioli, P Tacchetti, et al.
Journal of Experimental Pathology|January 1, 1987
Production and characterization of monoclonal antibodies (MoAbs) for the ex vivo purging of the bone marrow in patients with multiple myelomaA Dinota, P L Tazzari, A Bontadini, et al.
Pathologie-Biologie|October 1, 1990
Therapy of multiple myeloma. Italian Multiple Myeloma Study GroupM Boccadoro, G Avvisati, M Cantonetti, et al.
Cancer|February 15, 1982
Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemiaP Nanni, G Nicoletti, G Prodi, et al.
Transplantation|February 1, 1989
Bone marrow purging for multiple myeloma by avidin-biotin immunoadsorptionR M Lemoli, M Gobbi, P L Tazzari, et al.
Neurology|August 8, 2007
Neuropathy in multiple myeloma treated with thalidomide: a prospective studyR Plasmati, F Pastorelli, M Cavo, et al.
Haematologica|May 18, 1999
Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cellsG Martinelli, C Terragna, R M Lemoli, et al.
Blood|March 25, 2000
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapyR M Lemoli, G Martinelli, E Zamagni, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 25, 2019
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitorsM Mancini, S De Santis, C Monaldi, et al.
Leukemia|April 17, 2009
Ascorbic acid inhibits antitumor activity of bortezomib in vivoG Perrone, T Hideshima, H Ikeda, et al.
Pageof 15